Abstract
Protein kinase C (PKC) comprises a family of ubiquitously expressed phospholipid-dependent enzymes that regulate cell growth and differentiation. Several effectors that modify mammary cell biology work at least partially through PKC-dependent pathways. Studies with mammary epithelial cells and tissues have demonstrated probable roles for the PKCs in processes associated with carcinogenesis including proliferation, estrogen sensitivity, and apoptosis. The involvement of PKCs in this wide variety of responses may in part be explained by the expression of multiple PKCs in breast tissue and the possibility that individual PKCs selectively phosphorylate different proteins and preferentially mediate different biological responses. Further understanding of the role of individual PKCs in mammary cell growth and tumor promotion/progression is likely to lead to new insights for breast cancer diagnosis and treatment.
Similar content being viewed by others
Abbreviations
- PKC:
-
Protein kinase C
- DAG:
-
diacylglycerol
- PMA:
-
phorbol myristic acetate
- PLC:
-
phospholipase
- PC-PLC:
-
phosphatidylcholine-specific phospholipase C
References
Y. Nishizuka (1995). Protein kinases 5: Protein kinase C and lipid signaling for sustained cellular responses.FASEB J. 9:484–496.
S. Stabel (1994). Protein kinase C—an enzyme and its relatives.Sem. Cancer Biol. 5:277–284.
S. G. Rhee and K. D. Choi (1992). Regulation of inositol phospholipid-specific phospholipase-C isozymes.J. Biol. Chem. 267:12393–12396.
A. Kishimoto, K. Mikawa, K. Hashimoto, I. Yasuda, S. Tanaka, M. Tominaga, T. Kuroda, and Y. Nishizuka (1989). Limited proteolysis of protein kinase C subspecies by calcium-dependent neutral protease (calpain).J. Biol. Chem. 264:4088–4092.
D. Lindner, M. Gschwendt, and F. Marks (1992). Phorbol ester-induced down-regulation of the 80-kDa myristoylated alanine-rich C-kinase substrate-related protein in Swiss 3T3 fibroblasts—inhibition by staurosporine.J. Biol. Chem. 267:24–26.
N. T. Goode, M. A. N. Hajibagheri, and P. J. Parker (1995). Protein kinase C (PKC)-induced PKC down-regulation. Association with up-regulation of vesicle traffic.J. Biol. Chem. 270:2669–2673.
M. G. Kazanietz, L. B. Areces, A. Bahador, H. Mischak, J. Goodnight, J. F. Mushinski, and P. M. Blumberg (1993). Characterization of ligand and substrate specificity for the calcium-dependent and calcium-independent protein kinase-C isozymes.Mol. Pharmacol. 44:298–307.
S. L. Hyatt, T. Klauck, and S. Jaken (1990). Protein kinase C is localized in focal contacts of normal but not transformed fibroblasts.Mol. Carcinogen. 3:45–53.
L. Liao, K. Ramsay, and S. Jaken (1994). Protein kinase C isozymes in progressively transformed rat embryo fibroblasts.Cell Growth Diff. 5:1185–1194.
S. C. Kiley and P. J. Parker (1995). Differential localization of protein kinase C isozymes in U937 cells: evidence for distinct isozyme functions during monocyte differentiation.J. Cell Sci. 108: 1003–1016.
J. Goodnight, H. Mischak, W. Kolch, and J. F. Mushinski (1995). Immunocytochemical localization of eight protein kinase C isozymes overexpressed in NIH 3T3 fibroblasts. Isoform-specific association with microfilaments, Golgi, endoplasmic reticulum, and nuclear and cell membranes.J. Biol. Chem. 270:9991–10001.
H. Mischak, J. Goodnight, W. Kolch, G. Martiny-Baron, C. Schaechtle, M. G. Kazanietz, P. M. Blumberg, J. H. Pierce, and J. F. Mushinsk (1993). Overexpression of protein kinase C-δ and -ε in NIH 3T3 cells induces opposite effects on growth, morphology, anchorage dependence, and tumorigenicity.J. Biol. Chem. 268:6090–6096.
G. James and E. Olson (1992). Deletion of the regulatory domain of protein kinase-C α exposes regions in the hinge and catalytic domains that mediate nuclear targeting.J. Cell Biol. 116:863–874.
C. Lehel, Z. Oláh, G. Jakab, Z. Szállási, G. Petrovics, G. Harta, P. M. Blumberg, and W. B. Anderson (1995). Protein kinase C ε subcellular localization domains and proteolytic degradation sites. A model for protein kinase C conformational changes.J. Biol. Chem. 270:19651–19658.
S. L. Hyatt, L. Liao, C. Chapline, and S. Jaken (1994). Identification and characterization of α-protein kinase C binding proteins in normal and transformed REF52 cells.Biochemistry 33:1223–1228.
L. Liao, S. L. Hyatt, C. Chapline, and S. Jaken (1994). Protein kinase C domains involved in interactions with other proteins.Biochemistry 33:1229–1233.
S. Jaken, K. Leach, and T. Klauck (1989). Association of type 3 protein kinase C with focal contacts in rat embryo fibroblasts.J. Cell Biol. 109:697–704.
C. Chapline, K. Ramsay, T. Klauck, and S. Jaken (1993). Interaction cloning of protein kinase C substrates.J. Biol. Chem. 268:6858–6861.
S. L. Hyatt, L. Liao, A. Aderem, A. Nairn, and S. Jaken (1994). Correlation between protein kinase C binding proteins and substrates in REF52 cells.Cell Growth Diff. 5:495–502.
D. Ron, C. Chen, J. Caldwell, L. Jamieson, E. Orr, and D. Mochly-Rosen (1994). Cloning of an intracellular receptor for protein kinase C: A homolog of the β subunit of G proteins.PNAS 91:839–843.
J. Staudinger, J. Zhou, R. Burgess, S. J. Elledge, and E. N. Olson (1995). PICK1: A perinuclear binding protein and substrate for protein kinase C isolated by the yeast two-hybrid system.J. Cell Biol. 128:263–271.
U. T. Ruegg and G. M. Burgess (1989). Staurosporine, K-252 and UCN-01: potent but nonspecific inhibitors of protein kinases.Trends Pharmacol. Sci. 10:218–220.
M. G. Kazanietz, X. R. Bustelo, M. Barbacid, W. Kolch, H. Mischak, G. Wong, G. R. Pettit, J. D. Bruns, and P. M. Blumberg (1994). Zinc finger domains and phorbol ester pharmacophore. Analysis of binding to mutated form of protein kinase C ξ and thevav and c-raf proto-oncogene products.J. Biol. Chem. 269:11590–11594.
S. Ahmad and R. I. Glazer (1993). Expression of the antisense cDNA for protein kinase-c-α attenuates resistance in doxorubicin-resistant MCF-7 breast carcinoma cells.Mol. Pharmacol. 43:858–862.
N. M. Dean and R. McKay (1994). Inhibition of protein kinase C-α expression in mice after systemic administration of phosphorothioate antisense oligodeoxynucleotides.Proc. Natl. Acad. Sci. U.S.A. 91:11762–11766.
W. Li, J.-C. Yu, D.-Y. Shin, and J. H. Pierce (1995). Characterization of a protein kinase C-δ (PKC-δ) ATP binding mutant. An inactive enzyme that competitively inhibits wild type PKC-δ enzymatic activity.J. Biol. Chem. 270:8311–8318.
M. T. Diaz-Meco, E. Berra, M. M. Municio, L. Sanz, J. Lozano, I. Dominguez, V. Diazgolpe, M. T. L. Delera, J. Alcami, C. V. Paya, F. Arenzanaseisdedos, J. L. Virelizier, and J. Moscat (1993). A dominant negative protein kinase-C ξ-subspecies blocks NF-κ-B activation.Mol. Cell Bio. 13:4770–4775.
M. T. Diaz-Meco, J. Lozano, M. M. Municio, E. Berra, S. Frutos, L. Sanz, and J. Moscat (1994). Evidence for thein vitro andin vivo interaction ofras with protein kinase C zeta.J. Biol. Chem. 269:31706–31710.
S. M. Kahn, K. R. O'Driscoll, W. Jiang, C. Borner, D. B. Xu, M. A. Blackwood, Y. Zhang, K. Nomoto, and I. B. Weinstein (1994). Suppression of mitogenic activity by stable expression of the regulatory domain of PKCβ.Carcinogenesis 15:2919–2915.
F. S. Kittrell, C. J. Oborn, and D. Medina (1992) Development of mammary preneoplasiasin vitro from mouse mammary epithelial cell linesin vitro.Cancer Res. 52:1926–1932.
D. Medina, F. S. Kittrell, C. J. Oborn, and M. Schwartz (1993). Growth factor dependency and gene expression in preneoplastic mouse mammary epithelial cells.Cancer Res. 53:668–674.
D. Medina, F. S. Kittrell, Y. J. Liu, and M. Schwartz (1993). Morphological and functional properties of TM preneoplastic mammary outgrowths.Cancer Res. 53:663–667.
D. R. Welch, A. Neri, and G. L. Nicolson (1983). Comparison of ‘Spontaneous’ and ‘Experimental’ metastasis using rat 13762 mammary adenocarcinoma metastatic cell clones.Invasion Metastasis 3:65–80.
Y. Toh, S. D. Pencil, and G. L. Nicolson (1994). A novel candidate metastasis-associated gene,mtal, differentially expressed in highly metastatic mammary adenocarcinoma cell lines.J. Biol. Chem. 269:22958–22963.
C. Chapline, B. Mousseau, K. Ramsay, S. Duddy, Y. Li, S. Kiley, and S. Jaken (1995). Identification of a major protein kinase C binding protein and substrate in rat embryo fibroblasts: decreased expression in transformed cells.J. Biol. Chem. (submitted).
Y. Taketani and T. Oka (1983). Tumor promoter 12-O-tetrade-canoylphorbol 13-acetate stimulates proliferation and ductal morphogenesis and inhibits functional differentiation of normal rat mammary epithelial cells in primary culture.Proc. Natl. Acad. Sci. U.S.A. 80:1646–1649.
A. Starzec, E. Spanakis, A. Nehme, V. Salle, N. Veber, C. Mainguene, P. Planchon, A. Valette, G. Prevost, and L. Israel (1994). Proliferative effects of epithelial cells to 8-bromo-cyclic AMP and to a phorbol ester change during breast pathogenesis.J. Cell Physiol. 161:31–38.
T. Wada, K. M. Darcy, X. Guan, and M. M. Ip (1994). Phorbol 12-myristate 13-acetate stimulates proliferation and ductal morphogenesis and inhibits functional differentiation of normal rat mammary epithelial cells in primary culture.J. Cell Physiol. 158:97–109.
R. G. Mehta and R. C. Moon (1986). Effects of 12-O-tetradecanoylphorbol-13-acetate on carcinogen induced mouse mammary lesions in organ culture.Cancer Res. 46:5832–5835.
D. Fabbro, W. Kung, S. D. Costa, C. Borner, U. Regenass, and U. Eppenberger (1991). Involvement of protein kinase C in the growth regulation of human breast cancer cells. In R. B. Dickson and M. E. Lippman (eds.),Genes, Oncogenes, and Hormones, Kluwer Academic, Boston, pp. 229–248.
A. Valette, N. Gas, S. Jozan, F. Roubinet, M. Dupont, and F. Bayard (1987). Influence of 12-O-tetradecanoylphorbol-13-acetate on proliferation and maturation of human breast carcinoma cells (MCF-7): relationship to cell cycle events.Cancer Res. 47:1615–1620.
M. Koga, E. Musgrove, and R. Sutherland (1990). Differential effects of phorbol esters on epidermal growth factor receptors in estrogen receptor postive and negative breast cancer cell lines.Cancer Res. 50:4849–4855.
C. Borner, I. Filipuzzi, M. Wartmann, U. Eppenberger, and D. Fabbro (1989). Biosynthesis and posttranslational modifications of protein kinase C in human breast cancer cells.J. Biol. Chem. 264: 13902–13909.
M. J. Kennedy, L. J. Prestigiacomo, G. Tyler, W. S. May, and N. E. Davidson (1992). Differential effects of bryostatin-1 and phorbol ester on human breast cancer cell lines.Cancer Res. 52:1278–1283.
N. Guilbaud, M. F. Pichon, J. C. Faye, F. Bayard, and F. Valette (1988). Modulation of estrogen receptors by phorbol diesters in human breast MCF-7 cell line.Mol. Cell. Endocrinol. 56:157–163.
M. Tzukerman, X. Zhang, and M. Pfahl (1991). Inhibition of estrogen receptor activity by the tumor promoter 12-O-tetradecanoylphorbol-13-acetate: a molecular analysis.Mol. Endocrinol. 5:1983–1992.
S. Arnold, J. Obourn, H. Jaffe, and A. C. Notides (1994). Serine 167 is the major estradiol induced phosphorylation site on the human estrogen receptor.Mol. Endocrinol. 8: 1208–1214.
H. Cho and B. S. Katzenellenbogen (1993). Synergistic activation of estrogen receptor mediated transcription by estradiol and protein kinase activities.Mol. Endocrinol. 7:441–452.
G. Fuh and J. A. Wells (1995). Prolactin receptor antagonists that inhibit the growth of breast cancer cell lines.J. Biol. Chem. 270:13133–13137.
R. Banerjee and B. K. Vonderhaar (1992). Prolactin-induced protein kinase-C activity in a mouse mammary cell line (NOG-8).Mol. Cell. Endocrinol. 90:61–67.
B. M. Marte, T. Meyer, S. Stabel, J. R. Standke, S. Jaken, D. Fabbro, and N. E. Hynes (1994). Protein kinase C and mammary cell differentiation: involvement of protein kinase C α in the induction of β-casein expression.Cell Growth Diff. 5:1–10.
J. Rillema and S. B. Waters (1986). Phorbol myristate acetate stimulates RNA and casein synthesis in cultured mouse mammary gland tissues.Proc. Soc. Exp. Biol. Med. 182:11–14.
C. J. Ormandy, C. S. L. Lee, P. A. Kelly, and R. L. Sutherland (1993). Regulation of prolactin receptor expression by the tumor promoting phorbol ester 12-O-tetradecanoylphorbol-13-acetate in human breast cancer cells.J. Cell. Biochem. 52:47–56.
N. J. Kenney and R. B. Dickon (1996). Growth factor and sex steroid interactions in breast cancer.J. Mam. Gland Biol. Neoplasia. 1(2):189–198.
N. Hynes (1996). Erb2 activation and signal transduction in normal and malignant mammary cells.J. Mam. Gland Biol. Neoplasia 1(2):199–206.
T. Hunter, N. Ling, and J. A. Cooper (1984). Protein kinase C phosphorylation of the EGF receptor at a threonine residue close to the cytoplasmic face of the plasma membrane.Nature 311:480–483.
T. Hudson, J. Santon, and G. Gill (1995). Regulation of epidermal growth factor receptor gene expression.Mol. Endocrinol. 3:400–408.
N. Kyprianou, H. F. English, N. E. Davidson, and J. T. Isaacs (1991). Programmed cell death during regression of MCF-7 human breast cancer following estrogen ablation.Cancer Res. 51:162–166.
A. M. Warri, R. L. Huovinen, A. M. Laine, P. M. Martikainen, and P. L. Harkonen (1993). Apoptosis in toremifene-induced growth inhibition of human breast cancer cellsin vivo andin vitro.JNCI 85:1412–1418.
D. J. McConkey, P. Hartzell, M. Jondal, and S. Orrenius (1989). Inhibition of DNA fragmentation in thymocytes and isolated thymocyte nuclei by agents that stimulate protein kinase C.J. Biol. Chem. 264:13399–13402.
A. Geier, C. Weiss, R. Beery, M. Haimsohm, R. Hemi, Z. Malik, and A. Karasik (1995). Multiple pathways are involved in protection of MCF-7 cells against death due to protein synthesis inhibition.J. Cell Physiol. 163:570–576.
M. Bignon, J. Ogita, A. Kishimoto, and Y. Nishizuka (1990). Protein kinase C subspecies in estrogen receptor positive and negative human bresat cancer cell lines.Biochem. Biophys. Res. Commun. 171:1071–1078.
M. Simboli-Cambell and J. E. Welsh (1995). 1,25 Dihydroxyvitamin D3: coordinate regulator of active cell death and proliferation in MCF-7 breast cancer cells. In M. Tenniswood and H. Michna (eds.),Workshop on Apoptosis in Hormone Dependent Cancers, Springer Verlag, Berlin, pp. 181–200.
K. Kiguchi, D. Glesne, C. Chubb, H. Fujiki, and E. Huberman (1994). Differential induction of apoptosis in human breast cancer cells by okadaic acid and related inhibitors of protein phosphatases 1 and 2A.Cell Growth Diff. 5:995–1004.
J. Halstead, K. Kemp, and R. A. Ignotz (1995). Evidence for involvement of phosphatidycholine-phospholipase C and protein kinase C in transforming growth factor β signaling.J. Biol. Chem. 270:13600–13603.
M. Guerrin, H. Prats, P. Mazars, and A. Valette (1992). Antipro-liferative effect of phorbol esters on MCF-7 human breast adenocarcinoma cells: relationship with enhanced expression of transforming growth-factor β1.Biochem. Biophys. Acta 1137:116–120.
S. J. Kim, F. Denhez, K. Y. Kim, J. T. Holt, M. B. Sporn, and A. B. Roberts (1989). Activation of the second promoter of the transforming growth-factor β1 gene by transforming growth factor β1 and phorbol ester occurs through the same target sequences.J. Biol. Chem. 264:19373–19378.
G. Buellomo, M. Perotti, F. Taddei, F. Mirabelli, G. Finardi, P. Nicotera, S. Orrenius (1992). Tumor necrosis factor α induces apoptosis in mammary adenocarcinoma cells by an increase in intranuclear free calcuim concentration and DNA fragmentation.Cancer Res. 52:1342–1346.
R. A. Heller and M. Kronke (1994). Tumor necrosis factor receptor mediated signaling pathways.J. Cell Biol. 126:5–9.
L. Obeid and Y. A. Hannun (1995). Ceramide: a stress signal and mediator of growth suppression and apoptosis.J. Cell. Biochem. 58:191–198.
D. Jeoung, B. Tang, and M. Sonenberg (1995). Effects of tumor necrosis factor a on anti-mitogenicity and cell cycle related proteins in MCF-7.J. Biol. Chem. 270:18367–18373.
J. Lozano, E. Berra, M. M. Municio, M. T. Diaz-Meco, I. Dominguez, L. Sanz, and J. Moscat (1994). Protein kinase C ζ isoform is critical for kB-dependent promoter activation by sphinogmyelinase.J. Biol. Chem. 269:19200–19202.
H. Parenteau, T. F. Ho, L. A. Eckel, and K. K. Carroll (1992). Effects of a long-chain fatty amine on mammary carcinogenesis induced in female Sprague-Dawley rats by DMBA.Nutr. Cancer 17:235–241.
P. W. Sylvester, H. P. Birkenfeld, H. L. Hosick, and K. P. Briski (1994). Fatty acid modulation of epidermal growth factor-induced mouse mammary epithelial cell proliferationin vitro.Exp. Cell Res. 214:145–153.
T. Kano-Sueoka and M. E. Nicks (1993). Abnormal function of protein kinase C in cells having phosphatidylethanolamine-deficient and phosphatidylcholine-excess membranes.Cell Growth Diff. 4:533–537.
G. Yu, S. Ahmad, A. Aquino, C. R. Fairchild, J. B. Trepel, S. Ohno, K. Suzuki, T. Tsuruo, K. H. Cowan, and R. I. Glazer (1991). Transfection with protein kinase C-α confers increased multidrug resistance to MCF-7 cells expressing P-glycoprotein.Cancer Commun. 3:181–189.
A. Ahmed and R. I. Glazer (1993). Expression of the antisense cDNA for protein kinase C α attenuates resistance in doxorubicin-resistant MCF-7 breast carcinoma cells.Mol. Pharmacol. 43:858–862.
S. P. Hardy, H. R. Goodfellow, M. A. Valverde, D. R. Gill, F. V. Sepúlveda, and C. F. Higgins (1995). Protein kinase C-mediated phosphorylation of the human multidrug resistance P-glycoprotein regulates cell volume-activated chloride channels.EMBO J. 14:68–75.
S. Ahmad, A. R. Safa, and R. I. Glazer (1994). Modulation of P-glycoprotein by protein kinase C a in a baculovirus expression system.Biochemistry 33:10313–10318.
C. Faucher, J. Capdevielle, I. Canal, P. Ferrara, H. Mazarguil, W. L. Mcguire, and J. M. Darbon (1993). The 28-kda protein whose phosphorylation is induced by protein kinase C activators in MCF-7 cells belongs to the family of low molecular mass heat shock proteins and is the estrogen-regulated 24-kda protein.J. Biol. Chem. 268:15168–15173.
S. Osterreich, C. M. Weng, M. Qiu, S. G. Hisenbeck, C. K. Osborne, and S. Fuqua (1993). The small heat shock protein hsp27 is correlated with growth and drug resistance in human breast cancer cells.Cancer Res. 53:4443–4448.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kiley, S.C., Welsh, J., Narvaez, C.J. et al. Protein kinase C isozymes and substrates in mammary carcinogenesis. J Mammary Gland Biol Neoplasia 1, 177–187 (1996). https://doi.org/10.1007/BF02013641
Issue Date:
DOI: https://doi.org/10.1007/BF02013641